Pain Management in Head and Neck Surgery Patients

• Status: Withdrawn
• Trial end date: 2021-11-06
• Target enrollment: 0
• Participant gender: All

Summary

Our study aims to see if the addition of a scheduled non-opioid pain regimen will decrease the use and risk of opioid pain medications as well as improve pain control in head and neck surgery patients. Participants will be randomized to one of two pain regimens (opioid medication regimen vs combination regimen of opioid and non-opioid medications).

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Alabama at Birmingham
• Treatments: Acetaminophen; Acetaminophen, hydrocodone drug combination; Celecoxib; Gabapentin; Hydrocodone; Oxycodone

Criteria

Inclusion Criteria:

• age 18-69

• able to consent for themselves

• undergoing a "moderate" head and neck surgery at UAB, defined as procedures that generally require only 1-2 night stay in the hospital. For the purposes of this protocol, this will include patients undergoing neck dissections, glossectomy with primary closure, thyroidectomy, or parotidectomy

Exclusion Criteria:

• age < 18 or > 69

• unable to consent for themselves

• have a known opioid tolerance or are one a home opioid regimen prior to surgery

• known hepatic failure, renal failure, or sulfa allergy, as determined by standard of care labs drawn within 30 days of enrollment